Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-CACI 2024 Congresses
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
El Salvador 2024 Sessions
Arequipa 2024 Sessions
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/IASC Clinical Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Related Organizations
Institutional News
Contact
Search
Buscar
Buscar
Congreso SOLACI
SOLACI-CACI 2024
Certificados SOLACI-CACI 24
Presentaciones destacadas día 1
Presentaciones destacadas día 2
Presentaciones destacadas día 3
Notas y cobertura
Facebook
Instagram
Linkedin
Twitter
Youtube
Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-CACI 2024 Congresses
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
El Salvador 2024 Sessions
Arequipa 2024 Sessions
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/IASC Clinical Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Related Organizations
Institutional News
Contact
Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-CACI 2024 Congresses
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
El Salvador 2024 Sessions
Arequipa 2024 Sessions
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/IASC Clinical Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Related Organizations
Institutional News
Contact
Home
Structural heart disease
Valvular Aortic Valve
Valvular Aortic Valve
Valvular Aortic Valve
Valvular Aortic valve
Other
Hypertrophic Cardiomyopathy
Left Atrial Apendix Closure
Arterial Accesses
Valvular Aortic Valve
Ver Categoría
Other
TRI-SPA Study: Tricuspid Edge-to-Edge Treatment
Tricuspid regurgitation (TR) is a condition associated with high morbidity and mortality. Currently, surgery is the recommended...
Dr. Carlos Fava
-
25 November, 2024
Ver más
Structural heart disease
ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic...
Dr. Andrés Rodríguez
-
20 November, 2024
Ver más
Coronary disease
Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers
Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary...
Dr. Omar Tupayachi
-
13 November, 2024
Ver más
Mitral valve
TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement
Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality. Edge-to-edge repair has...
Dr. Carlos Fava
-
11 November, 2024
Ver más
Structural Heart Disease
TCT 2024 – TAVR UNLOAD: Moderate Aortic Stenosis with Ventricular Function Deterioration
The prevalence of aortic stenosis (AS) is on the rise in developed countries, and the link between...
Dr. Carlos Fava
-
7 November, 2024
Ver más
Coronary disease
Evolution of Small Balloon-Expandable Valves
Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation...
Dr. Carlos Fava
-
5 November, 2024
Ver más
Antithrombotic Anticoagulants
TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?
The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series....
Dr. Carlos Fava
-
24 October, 2024
Ver más
Structural heart disease
ENVISAGE-TAVI AF Trial: What Anticoagulant Should We Use?
Between 15% and 30% of patients undergoing TAVR present atrial fibrillation. Many of them have suffered ischemic...
Dr. Carlos Fava
-
23 September, 2024
Ver más